59160-29-1

59160-29-1 structure
59160-29-1 structure
  • Name: Lidofenin
  • Chemical Name: N-(2,6-Dimethylphenylcarbamoylmethyl)iminodiacetic Acid
  • CAS Number: 59160-29-1
  • Molecular Formula: C14H18N2O5
  • Molecular Weight: 294.30
  • Catalog: Chemical reagent Organic reagent fatty acid
  • Create Date: 2019-01-12 17:26:37
  • Modify Date: 2024-01-04 15:26:04
  • Lidofenin is an iminodiacetic acid (IDA) derivative. Lidofenin can be used for hepatobiliary research[1].

Name N-(2,6-Dimethylphenylcarbamoylmethyl)iminodiacetic Acid
Synonyms 2-[carboxymethyl-[2-(2,6-dimethylanilino)-2-oxoethyl]amino]acetic acid
EINECS 261-636-4
MFCD00038399
Description Lidofenin is an iminodiacetic acid (IDA) derivative. Lidofenin can be used for hepatobiliary research[1].
Related Catalog
References

[1]. Chiotellis E, Sawas-Dimopoulou C, Koutoulidis C, Constantinides M. 99MTc-HIDA, a gallbladder imaging agent: experimental aspects. Eur J Nucl Med. 1978;3(1):41-6  

Density 1.352 g/cm3
Boiling Point 546.3ºC at 760 mmHg
Melting Point 210ºC (dec.)(lit.)
Molecular Formula C14H18N2O5
Molecular Weight 294.30
Flash Point 284.2ºC
Exact Mass 294.12200
PSA 106.94000
LogP 0.78610
Index of Refraction 1.5110 (estimate)
Name: N-(2 6-Dimethylphenylcarbamoyl-Methyl)-Iminodiacetic Acid 99% Material Safety Data Sheet
Synonym: Acetic Acid, (((2,6-Xylylcarbamoyl)methyl)imino)di-; Glycine, N-(Carboxymethyl)-N-(2-((2,6-Dimethylphenyl)amino)-2-Oxoethyl)-
CAS: 59160-29-1
Section 1 - Chemical Product MSDS Name:N-(2 6-Dimethylphenylcarbamoyl-Methyl)-Iminodiacetic Acid 99% Material Safety Data Sheet
Synonym:Acetic Acid, (((2,6-Xylylcarbamoyl)methyl)imino)di-; Glycine, N-(Carboxymethyl)-N-(2-((2,6-Dimethylphenyl)amino)-2-Oxoethyl)-

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
59160-29-1 Glycine, N-(Carboxymethyl)-N-2-(2,6-Di 99 261-636-4
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 59160-29-1: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Powder
Color: white
Odor: none reported
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 213.00 - 216.00 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: soluble
Specific Gravity/Density:
Molecular Formula: C14H18N2O5
Molecular Weight: 294.30

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 59160-29-1: AH1846000 LD50/LC50:
Not available.
Carcinogenicity:
Glycine, N-(Carboxymethyl)-N-2-(2,6-Dimethylphenyl)Amino2-Oxo - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 59160-29-1: No information available.
Canada
CAS# 59160-29-1 is listed on Canada's NDSL List.
CAS# 59160-29-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 59160-29-1 is listed on the TSCA inventory.


SECTION 16 - ADDITIONAL INFORMATION
N/A

CHEMICAL IDENTIFICATION

RTECS NUMBER :
AH1846000
CHEMICAL NAME :
Acetic acid, 2,2'-(N-(2,6-dimethylphenylcarbamoylmethyl)imino)di-
CAS REGISTRY NUMBER :
59160-29-1
LAST UPDATED :
199701
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C14-H18-N2-O5
MOLECULAR WEIGHT :
294.34
WISWESSER LINE NOTATION :
QV1N1VQ1VMR B1 F1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
88 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - mydriasis (pupillary dilation) Cardiac - change in rate Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 6,1331,1978
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1100 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
EJNMD9 European Journal of Nuclear Medicine. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1976- Volume(issue)/page/year: 3,41,1978
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Parenteral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
168 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JNMEAQ Journal of Nuclear Medicine. (Samuel N. Turiel & Associates, Inc., 4 30 North Michigan Avenue, Chicago, IL, DElaware 7-3511) V.1- 1960- Volume(issue)/page/year: 18,997,1977
Hazard Codes Xi: Irritant;
Risk Phrases 36/37/38
Safety Phrases S26;S36
WGK Germany 3
RTECS AH1846000
HS Code 2924299090

~%

59160-29-1 structure

59160-29-1

Literature: Mikiciuk-Olasik, Elzbieta; Wojewoda, Emilia; Bilichowski, Ireneusz; Witczak, Malgorzata; Karwowski, Boleslaw; Wagrowska-Danilewicz, Malgorzata; Stasikowska, Olga Acta Poloniae Pharmaceutica - Drug Research, 2010 , vol. 67, # 2 p. 119 - 127
Precursor  1

DownStream  0

HS Code 2924299090
Summary 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%